Massachusetts
CNS trials open to children and teens in Massachusetts
25 CNS studies open to children and teens are recruiting participants at sites in 7 cities across Massachusetts as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Massachusetts city with a recruiting study
By research area: Depression (12), ADHD (7), Epilepsy (4), Schizophrenia (2).
Boston (20), Belmont (2), Springfield (2), Worcester (2), Brookline (1), Cambridge (1), Charlestown (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
ADHD: recently updated in Massachusetts
Basic details from each study's public record (the 12 most recently updated of 25). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Springfield · Worcester
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Springfield · Worcester
- Registry record
- NCT07717892 · updated
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Recruiting in
- Boston
- Registry record
- NCT05916339 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Boston
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Massachusetts on ClinicalTrials.gov.
Depression: recently updated in Massachusetts
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Brookline
- Registry record
- NCT04777357 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Recruiting in
- Boston
- Registry record
- NCT07048574 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Boston
- Registry record
- NCT07227454 · updated
Teenthrive 2: Treatments for Improving Mood in Teens
- No phase
- Ages 12 to 18
- All sexes
- Sponsor
- Butler Hospital
- Recruiting in
- Boston
- Registry record
- NCT07475845 · updated
Preventing Depression of Chinese American Adolescents by RRE
- No phase
- Ages 14 to 18
- All sexes
- Sponsor
- Northeastern University
- Recruiting in
- Boston
- Registry record
- NCT05921201 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Massachusetts on ClinicalTrials.gov.
Epilepsy: recently updated in Massachusetts
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Recruiting in
- Boston
- Registry record
- NCT07227857 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Massachusetts on ClinicalTrials.gov.
Schizophrenia: recently updated in Massachusetts
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Phase 3
- Ages 13 to 17
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Boston
- Registry record
- NCT07288567 · updated
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Recruiting in
- Boston
- Registry record
- NCT07424404 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Massachusetts on ClinicalTrials.gov.
Ask about studies in Massachusetts
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections